Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors | |||
| Speakers | Dr Rani Khatib, Consultant Pharmacist in Cardiology and Cardiovascular Research, Leeds Teaching Hospitals NHS Trust | |||
| Satellite Description | ||||
|
This session has been sponsored, including speaker honoraria and presentation development support, by the Boehringer Ingelheim and Lilly Diabetes Alliance PC-GB-100225 September 2019 | ||||
